EurekaMag PDF full texts Chapter 67,752
References:
Lai, I.C.; Hong, C.-J.; Tsai, S.-J. 2001: Association Study of a Nicotinic Receptor Variant with Schizophrenic Disorders. Neuropsychobiology 43(1): 15-18
Lara, D.R.; Vianna, M.ô , nicaR.M.; de Paris, F.; Quevedo, J.ã o, o; Oses, J.P.; Battastini, A.M.O.; Sarkis, J.ã , oJ.F.; Souza, D.O. 2001: Chronic Treatment with Clozapine, but Not Haloperidol, Increases Striatal Ecto-5′-Nucleotidase Activity in Rats. Neuropsychobiology 44(2): 99-102
Born, J.; Wagner, U. 2001: Memory Formation in Sleep: Giving a Wave to Dreams. Neuropsychobiology 44(4): 212-214
Reiser, M.; Borchmann, P.; Diehl, V.; Engert, A. 1998: Ifosfamide in the Treatment of Relapsed Lymphoma. Oncology Research and Treatment 21(2): 26-29
Eidtmann, H. 1999: Kontroversen der axillren Lymphonodektomie (Sln). Oncology Research and Treatment 22(2): 18-21
Kühn, T.; Kreienberg, R. 2000: Surgical Treatment of Breast Cancer Current Status and New Concepts. Oncology Research and Treatment 23(6): 524-525
Schulz, H.; Winkler, U.; Staak, J.O.; Engert, A. 2000: The Monoclonal Antibodies Campath-1H and Rituximab in the Therapy of Chronic Lymphocytic Leukemia. Oncology Research and Treatment 23(6): 526-532
Bausewein, C.; Hartenstein, R. 2000: Oncology and Palliative Care. Oncology Research and Treatment 23(6): 534-537
Dannull, J.; Cerny, T.; Ackermann, D.K.; Groettrup, M. 2000: Current Status of Dendritic Cell-Based Tumor Vaccination. Oncology Research and Treatment 23(6): 544-551
Schulz, A.; Scheid, C.; Fuchs, M.; Abelius, R.; Diehl, V.; Söhngen, D. 2000: Recent Developments in Hematology and Transfusion Medicine. Oncology Research and Treatment 23(6): 552-555
von Rohr, E.; Pampallona, S.; van Wegberg, B.; Cerny, T.; Hürny, C.; Bernhard, J.; Helwig, S.; Heusser, P. 2000: Attitudes and Beliefs towards Disease and Treatment in Patients with Advanced Cancer Using Anthroposophical Medicine. Oncology Research and Treatment 23(6): 558-563
Bottke, D.; Wiegel, T.; Kreusel, K.-M.; Bornfeld, N.; Schaller, G.; Hinkelbein, W. 2000: Radiotherapy of Choroidal Metastases in Patients with Disseminated Cancer. Oncology Research and Treatment 23(6): 572-575
Kahl, C.; Florschütz, A.; Jentsch-Ullrich, K.; Dietzmann, K.; Franke, A. 2000: Primary Intracranial Manifestation of Cd7/Cd56-Positive Acute Myelogenous Leukemia. Oncology Research and Treatment 23(6): 580-582
Gesierich, W.; Munker, R.; Geiersberger, U.; Pohlmann, H.; Brack, N.; Hartenstein, R. 2000: Spontaneous Bleeding in a Patient with Malignant Lymphoma: A Case of Acquired Hemophilia. Oncology Research and Treatment 23(6): 584-588
Liesenfeld, S.M.; Wendt, T.G. 2000: Clinical Implications of 3D-Conformal Radiotherapy. Oncology Research and Treatment 23(6): 590-592
Sevelda, P. 2000: Second-line-Therapie des Ovarialkarzinoms. Oncology Research and Treatment 23(6): 593-596
Pfleiderer, A. 2000: Meilensteine der gynkologischen Onkologie in den letzten 20 Jahren. Oncology Research and Treatment 23(6): 615-618
Schüller, J. 2000: Wirkprinzip sowie Serum- und Gewebepharmakokinetik von Caelyx bei Patientinnen mit fortgeschrittenem Mammakarzinom. Oncology Research and Treatment 23(2): 3-6
Thomssen, C. 2000: Anthrazykline in der adjuvanten Therapie des Mammakarzinoms. Oncology Research and Treatment 23(2): 7-11
Untch, M.; Crohns, C.; Kahlert, S.; Hepp, H. 2000: Anthrazykline und Herceptin als neue Therapieoption beim metastasierten Mammakarzinom. Oncology Research and Treatment 23(2): 15-19
Möbus, V. 2000: Erfahrungen mit Caelyx in der Therapie des metastasierten Mammakarzinoms. Oncology Research and Treatment 23(2): 20-25
Meier, W.; Gropp, M.; Burges, A.; Hepp, H. 2000: Therapie bei Progression und Rezidiv des Ovarialkarzinoms. Oncology Research and Treatment 23(2): 35-39
Bauknecht, T. 2000: Caelyx in der Therapie des fortgeschrittenen Ovarialkarzinoms. Oncology Research and Treatment 23(2): 40-45
du Bois, A. 2000: Anthrazykline in der Therapie des Ovarialkarzinoms Vergangenheit, Gegenwart und Zukunft. Oncology Research and Treatment 23(2): 46-52
Eisenhauer, E.A. 2000: Phase I and Phase Ii Evaluation of Novel Anticancer Agents: Are Response and Toxicity the Right Endpoints?. Onkologie 23(Suppl 3): 2-6
Wolf, M. 2000: Topotecan in the First-Line Treatment of Small-Cell Lung Cancer. Onkologie 23(Suppl 3): 13-17
Nabholtz, J.-M. 2000: Docetaxel in the Adjuvant Setting. Oncology Research and Treatment 23(6): 10-12
Wilke, H.W. 2000: Kombination mit Irinotecan die Referenztherapie in der First-line-Therapie des fortgeschrittenen Kolorektalkarzinoms. Oncology Research and Treatment 23(6): 32-34
Mickisch, G.H.J. 2001: Early versus Deferred Hormonal Treatment for Asymptomatic Prostate Cancer. Oncology Research and Treatment 24(3): 214-220
Kolotas, C.; Zamboglou, N. 2001: Role of Interstitial Brachytherapy in the Treatment of Malignant Disease. Oncology Research and Treatment 24(3): 222-228
Kübler, A.C.; Scheer, M.; Zöller, J.E. 2001: Photodynamic Therapy of Head and Neck Cancer. Oncology Research and Treatment 24(3): 230-237
Schackert, G.; Steinmetz, A.; Meier, U.; Sobottka, S.B. 2001: Surgical Management of Single and Multiple Brain Metastases: Results of a Retrospective Study. Oncology Research and Treatment 24(3): 246-255
Oberhoff, C.; Kieback, D.G.; Würstlein, R.; Deertz, H.; Sehouli, J.; van Soest, C.; Hilfrich, J.; Mesrogli, M.; von Minckwitz, G.; Staab, H.J.; Schindler, A.E. 2001: Topotecan Chemotherapy in Patients with Breast Cancer and Brain Metastases: Results of a Pilot Study. Oncology Research and Treatment 24(3): 256-260
Petera, J.; Filip, S.; Šlampa, P.; Soumarová, R.; Čoupek, P.; Zatloukal, P. 2001: Management of Inoperable Carcinoma of the Breast by Curative Radiotherapy and Chemo-hormonotherapy. Oncology Research and Treatment 24(3): 263-266
Heim, M.E.; Kunert, S.; Özkan, I. 2001: Effects of Inpatient Rehabilitation on Health-Related Quality of Life in Breast Cancer Patients. Oncology Research and Treatment 24(3): 268-272
Samel, S.; Hofheinz, R.; Hundt, A.; Sturm, J.; Knoll, M.R.; Wenz, F.; Queisser, W.; Post, S. 2001: Neoadjuvant Radio-Chemotherapy of Adenocarcinoma of the Oesophagogastric Junction. Oncology Research and Treatment 24(3): 278-282
Wendt, T.G. 2001: Klinische Strahlentherapie im 19. und 20. Jahrhundert: Historie und Ausblick. Oncology Research and Treatment 24(3): 296-298
Schrader, M.; Heicappell, R.; Müller, M.; Straub, B.; Miller, K. 2001: Impact of Chemotherapy on Male Fertility. Oncology Research and Treatment 24(4): 326-330
Krauss, T.; Huschmand Nia, A.; Viereck, V.; Emons, G. 2001: New Developments in the Treatment of Cervical Cancer. Oncology Research and Treatment 24(4): 340-345
Musch, E.; Malek, M.; Lammering, G.; Linden-Lammering, S.; Hartlapp, J.H.; Chrissafidou, A. 2001: Palliation by Intratumoral Infiltration with Natural Interferon-beta. Oncology Research and Treatment 24(4): 362-366
Trojan, A.; Stallmach, T.; Kollias, S.; Pestalozzi, B.C. 2001: Inflammatory Myofibroblastic Tumor with Cns Involvement. Oncology Research and Treatment 24(4): 368-372
Fazeny-Dörner, B.; Piribauer, M.; Marosi, C. 2001: Multimodale Therapie hochmaligner Gliome des Erwachsenen. Oncology Research and Treatment 24(4): 376-379
Hehlmann, R. 2001: Die Bedeutung der Vernetzung fr die klinische Forschung der Zukunft. Oncology Research and Treatment 24(4): 380-384
Genvresse, I.; Wedding, U.; Bokemeyer, C.; Späth-Schwalbe, E. 2001: Behandlung des multiplen Myeloms bei lteren Patienten: Konsensus der Arbeitsgruppe Geriatrische Onkologie der Dgho und Dgg. Oncology Research and Treatment 24(4): 386-390
Steinmetz, H.T.; Schmitz, S. 2001: Qualittsmanagement und Zertifizierung in der Onkologie. Oncology Research and Treatment 24(4): 391-394
Boll, I.T.M. 2001: Documentation of Normal and Leukemic Myelopoietic Progenitor Cells with High-Resolution Phase-Contrast Time-Lapse Cinematography. Oncology Research and Treatment 24(4): 395-402
Malayeri, R.; Pirker, R.; Huber, H. 2001: New Drugs in the Palliative Chemotherapy of Advanced Non-Small-Cell Lung Cancer. Oncology Research and Treatment 24(5): 416-421
Kirsch, M.; Santarius, T.; Black, P.M.; Schackert, G. 2001: Therapeutic Anti-Angiogenesis for Malignant Brain Tumors. Oncology Research and Treatment 24(5): 423-430
Dworzak, M.N. 2001: Immunological Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia. Oncology Research and Treatment 24(5): 442-448
Henke, M. 2001: Correction of Cancer Anemia Impact on Disease Course, Prognosis and Treatment Efficacy, Particularly for Patients Undergoing Radiotherapy. Oncology Research and Treatment 24(5): 450-454
Serrone, L.; Zeuli, M.; Papaldo, P.; Nardoni, C.; Pacetti, U.; Cognetti, F. 2001: Ifosfamide and Epirubicin Combination in Untreated Sarcomas: Two Treatment Schedules. Oncology Research and Treatment 24(5): 465-468
Neise, C.; Rauchfuss, M.; Paepke, S.; Beier, K.; Lichtenegger, W. 2001: Risk Perception and Psychological Strain in Women with a Family History of Breast Cancer. Oncology Research and Treatment 24(5): 470-475
Dencausse, Y.; Sturm, J.; Hartung, G.; Dietzler, P.; Edler, L.; Bambach, M.; Wojatschek, C.; Lindemann, H.; Qeißer, W. 2001: Adjuvant Radio-Chemotherapy in Stage IiIii Rectal Cancer with 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid: Evaluation of Feasibility. Oncology Research and Treatment 24(5): 476-480
Krause, M.; Tunn, P.-U.; Schneider, U. 2001: Hemangiosarcoma of the Bone. Problems Arising from the Heterogeneity of Malignant Vascular Tumors of the Bone. Oncology Research and Treatment 24(5): 486-489
Golder, W. 2001: Positron Emission Tomography and Lymphoma Therapy. Oncology Research and Treatment 24(5): 496-498
Kornek, G.V. 2001: Internistisch-onkologisches Therapiemanagement bei lteren Patienten. Oncology Research and Treatment 24(5): 499-504
Queisser, W. 2001: Praxis fr prventive Onkologie. Oncology Research and Treatment 24(5): 505-512
Buchheidt, D.; Spiess, B.; Hehlmann, R. 2001: Systemic Infections with Aspergillus Species in Patients with Hematological Malignancies: Current Serological and Molecular Diagnostic Approaches. Oncology Research and Treatment 24(6): 531-536
Munker, R.; Purmale, L.; Aydemir, .; Reitmeier, M.; Pohlmann, H.; Schorer, H.; Hartenstein, R. 2001: Advanced Head and Neck Cancer: Long-Term Results of Chemo-Radiotherapy, Complications and Induction of Second Malignancies. Oncology Research and Treatment 24(6): 553-558
Hadjieva, T. 2001: Scoring Patients Risk in Differentiated Thyroid Cancer. Oncology Research and Treatment 24(6): 561-568
Mitterer, S.; Schratter-Sehn, A.U. 2001: Three Years Experience in the Development of a Dynamic Quality Management Concept in a Digitized Radiotherapy Department. Oncology Research and Treatment 24(6): 570-575
Coşkun, U.; Gunel, N.; Yamac, D.; Altinova, A.E. 2001: Effect of Cisplatin on Skin Metastasis in Breast Cancer Patients. Oncology Research and Treatment 24(6): 576-579
Eleftheriadis, N.; Pistevou-Gombaki, K.; Plataniotis, G.; Sofroniadis, I.; Kouloulias, V. 2001: Is External Palliative Radiotherapy for Gallbladder Carcinoma Effective?. Oncology Research and Treatment 24(6): 581-584
Berdel, W.E.; Zühlsdorf, M.; Nippert, R.P.; Marschall, B.; Wilhelm, M.J.; Stümpel, F.; Herbst, H.; Kliesch, S.; Ramsthaler, F.; Domschke, W. 2001: Problemorientiertes Lernen interdisziplinre Tumormedizin (poL-iT): Ein integriertes Modell der Universitt Mnster. Oncology Research and Treatment 24(6): 587-594
Marmé, D. 2001: Tumorangiogenese: Neue Anstze zur Krebstherapie. Oncology Research and Treatment 24(1): 1-5
Wajant, H.; Pfizenmaier, K. 2001: Vom Tumornekrosefaktor zum Trail-Amaize: Antitumoral wirksame Zytokine der zweiten Generation. Oncology Research and Treatment 24(1): 6-10
Queisser, W. 2001: Gerd A. Nagel und die Zeitschrift Onkologie. Oncology Research and Treatment 24(1): V-Vi
Schuff-Werner, P.; Zingler, C. 2001: Mgliche Bedeutung eines positiven Psa-Nachweises bei Patientinnen mit benignen und malignen Erkrankungen der Brust. Oncology Research and Treatment 24(1): 11-17
Unger, C.; Eibl, H. 2001: Arzneimittelentwicklung aus Phospholipiden. Oncology Research and Treatment 24(1): 18-23
Ansén, S.; Engert, A.; Wolf, J.; Sieber, M.; Paulus, U.; Diehl, V. 2001: Deutsche Hodgkin-Lymphom-Studiengruppe (Dhsg): 20 Jahre Diagnostik, Therapie und Nachsorge von Patienten mit Morbus Hodgkin. Oncology Research and Treatment 24(1): 35-48
Bartsch, H.H. 2001: Stellenwert und Perspektiven der Rehabilitation onkologischer Patienten in Deutschland. Oncology Research and Treatment 24(1): 68-73
Etzel, B.S. 2001: Pflege in der Klinik fr Tumorbiologie Freiburg auf dem Weg. Oncology Research and Treatment 24(1): 80-85
Pistorius, S.; Schackert, H.K.; Saeger, H.-D. 2001: Hereditre kolorektale Karzinome berlegung zu prventiven chirurgischen Manahmen. Oncology Research and Treatment 24(5): 4-8
Hartung, G. 2001: Neue Entwicklungen in der Chemotherapie gastrointestinaler Tumoren. Oncology Research and Treatment 24(5): 10-15
Heim, M.E. 2001: Rehabilitation in der integrativen Behandlung von Krebskranken. Oncology Research and Treatment 24(5): 16-20
Flechtner, H. 2001: Lebensqualitt in onkologischen Studien. Oncology Research and Treatment 24(5): 22-27
Neises, M. 2001: Krankheitsbewltigung und Lebensqualitt aus gynkologisch-psychosomatischer Sicht. Oncology Research and Treatment 24(5): 28-34
Sturm, J.W.; Keese, M.A.; Bönninghoff, R.G.; Wüstner, M.; Post, S. 2001: Lokal ablative Therapien des hepatozellulren Karzinoms. Oncology Research and Treatment 24(5): 35-45
Siegsmund, M.; Musial, A.; Weiß, J.; Alken, P. 2001: Die Ldr-Brachytherapie, eine minimal invasive Alternative in der Therapie des organbegrenzten Prostatakarzinoms. Oncology Research and Treatment 24(5): 46-50
Wenz, F.; Tiefenbacher, U.; Willeke, F.; Weber, K.-J. 2001: Auf der Suche nach der Therapeutischen Breite in der Radioonkologie. Oncology Research and Treatment 24(5): 51-55
Schadendorf, D. 2001: Tumorspezifische Therapieanstze in der Onkologie. Oncology Research and Treatment 24(5): 56-59
Löhr, M.; Faulmann, G.; Hummel, F.; Singer, M.V. 2001: Gentherapie des Pankreaskarzinoms mit mikroverkapselten, Cyp2B1-exprimierenden Zellen. Oncology Research and Treatment 24(5): 60-64
Hochhaus, A.; Lahaye, T.; Kreil, S.; Berger, U.; Metzgeroth, G.; Hehlmann, R. 2001: Selektive Hemmung von Tyrosinkinasen als neues therapeutisches Prinzip in der Onkologie. Oncology Research and Treatment 24(5): 65-71
Fischer, J.R.; Neuner, A.; Muley, T.; Lahm, H.; Drings, P. 2001: Neue Aspekte der Immunbiologie des nichtkleinzelligen Bronchialkarzinoms. Oncology Research and Treatment 24(5): 72-74
Weber, A.; Tannapfel, A.; Wittekind, C.; Bootz, F. 2002: Carcinogen-Induced Site-Specific Mutagenesis and Genetic Susceptibility in Squamous Cell Carcinoma of the Head and Neck. Oncology Research and Treatment 25(1): 8-13
Goebel, U.; Calaminus, G.; Schneider, D.T.; Schmidt, P.; Haas, R.J. 2002: Management of Germ Cell Tumors in Children: Approaches to Cure. Oncology Research and Treatment 25(1): 14-22
Strobel, E.-S.; Fritschka, E. 2002: Hereditary Premenopausal Breast Cancer. Oncology Research and Treatment 25(1): 24-27
Golder, W. 2002: Functional Magnetic Resonance Imaging Basics and Applications in Oncology. Oncology Research and Treatment 25(1): 28-31
Gerstner, A.O.H.; Machlitt, J.; Laffers, W.; Tárnok, A.; Bootz, F. 2002: Analysis of Minimal Sample Volumes from Head and Neck Cancer by Laser Scanning Cytometry. Oncology Research and Treatment 25(1): 40-46
Albers, P.; Siener, R.; Haertlein, M.; Fallahi, M.; Haeutle, D.; Perabo, F.G.E.; Steiner, G.; Blatter, J.; Mueller, S.C. 2002: Gemcitabine Monotherapy as Second-Line Treatment in Cisplatin-Refractory Transitional Cell Carcinoma Prognostic Factors for Response and Improvement of Quality of Life. Oncology Research and Treatment 25(1): 47-52
Mai, S.K.; Grieger, J.; Lachmann, R.; Bohrer, M.; Tiefenbacher, U.; Wenz, F. 2002: Radiochemotherapy for Anal Carcinoma Effectivity and Late Toxicity. Oncology Research and Treatment 25(1): 55-59
Stemmler, J.; Weise, A.; Hacker, U.; Heinemann, V.; Schalhorn, A. 2002: Weekly Irinotecan in a Patient with Metastatic Colorectal Cancer on Hemodialysis due to Chronic Renal Failure. Oncology Research and Treatment 25(1): 60-63
Bohrer, M.; Wenz, F. 2002: Prophylactic Cranial Irradiation in Limited-Disease Small-Cell Lung Cancer Why, When, How Much?. Oncology Research and Treatment 25(1): 66-68
Schlag, P.M.; Hünerbein, M. 2002: Minimal Access Surgery for Cancer Treatment. Oncology Research and Treatment 25(1): 72-73
Schadendorf, D. 2002: Is There a Standard for the Palliative Treatment of Melanoma?. Oncology Research and Treatment 25(1): 74-76
Schmid, P.; Possinger, K. 2002: High-Dose Chemotherapy in High-Risk Primary Breast Cancer. Oncology Research and Treatment 25(2): 112-120
Teymoortash, A.; Werner, J.A. 2002: Value of Neck Dissection in Patients with Cancer of the Parotid Gland and a Clinical N0 Neck. Oncology Research and Treatment 25(2): 122-126
Ugurel, S.; Reinhold, U.; Tilgen, W. 2002: Hla-G in Melanoma: A New Strategy to Escape from Immunosurveillance?. Oncology Research and Treatment 25(2): 129-134
Weber, K.-J.; Wenz, F. 2002: P53, Apoptosis and Radiosensitivity Experimental and Clinical Data. Oncology Research and Treatment 25(2): 136-141
D'Addario, G.; Morant, R.; Boehme, C.; Cerny, T. 2002: Feasibility and Toxicity of Weekly Paclitaxel-Carboplatin in 131 Patients with Pretreated and Non-Pretreated Solid Tumors. Oncology Research and Treatment 25(2): 152-157
Voigt, W.; Behrmann, C.; Schlueter, A.; Kegel, T.; Grothey, A.; Schmoll, H.-J. 2002: A New Chemoembolization Protocol in Refractory Liver Metastasis of Colorectal Cancer a Feasibility Study. Oncology Research and Treatment 25(2): 158-164
Pampallona, S.; von Rohr, E.; van Wegberg, B.; Bernhard, J.; Helwig, S.; Heusser, P.; Huerny, C.; Schaad, R.; Cerny, T. 2002: Socio-Demographic and Medical Characteristics of Advanced Cancer Patients Using Conventional or Complementary Medicine. Oncology Research and Treatment 25(2): 165-170
Otto, T.; Luemmen, G.; Bex, A.; Suhr, J.; Goebell, P.J.; Raz, A.; Ruebben, H. 2002: Tumor Cell Motility as a Novel Target in Cancer Experimental and Clinical Results. Oncology Research and Treatment 25(2): 172-177
Tesche, S.; Sagowski, C.; Zywietz, F.; Jenicke, L.; Bohuslavizki, K.H.; Metternich, F.U. 2002: Multiple Application of Drugs in Rats a New Port System. Oncology Research and Treatment 25(2): 178-180
Stemmler, J.; Heinemann, V.; Schalhorn, A. 2002: Capecitabine as Second-Line Treatment for Metastatic Cholangiocarcinoma: A Report of Two Cases. Oncology Research and Treatment 25(2): 182-184
Queisser, W. 2002: Konzeptausbau und Beitragsentwicklung der Zeitschrift Onkologie von 19782002. Oncology Research and Treatment 25(1): 1-4
Wendt, T.G. 2002: Perspektiven und Entwicklungen in der Radioonkologie der letzten 25 Jahre. Oncology Research and Treatment 25(1): 15-20
Vutuc, C. 2002: Tumorepidemiologie eine Standortbestimmung. Oncology Research and Treatment 25(1): 44-47
Kato, S.; Kitamoto, T.; Masuhiro, Y.; Yanagisawa, J. 1998: Molecular Mechanism of a Cross-Talk between Estrogen and Growth-Factor Signaling Pathways. Oncology 55(1): 5-10
Iwase, H.; Omoto, Y.; Iwata, H.; Hara, Y.; Ando, Y.; Kobayashi, S. 1998: Genetic and Epigenetic Alterations of the Estrogen Receptor Gene and Hormone Independence in Human Breast Cancer. Oncology 55(1): 11-16
Yamashita, J.; Abe, M.; Ogawa, M. 1998: Endocrine Therapy in Pancreatic Carcinoma. Oncology 55(1): 17-22
Kurebayashi, J.; Otsuki, T.; Yamamoto, S.; Kurosumi, M.; Nakata, T.; Akinaga, S.; Sonoo, H. 1998: A Pure Antiestrogen, Ici 182,780, Stimulates the Growth of Tamoxifen-Resistant Kpl-1 Human Breast Cancer Cells in vivo but not in vitro. Oncology 55(1): 23-34
Fujimoto, J.; Hirose, R.; Sakaguchi, H.; Tamaya, T. 1998: Estrogen Dependency in Uterine Endometrial Cancers. Oncology 55(1): 53-59
Brito, R.A.; Medgyesy, D.; Zukowski, T.H.; Royce, M.E.; Ravandi-Kashani, F.; Hoff, P.M.; Pazdur, R. 1999: Fluoropyrimidines: A Critical Evaluation. Oncology 57(Suppl 1): 2-8
Verweij, J. 1999: Rational Design of New Tumoractivated Tm Cytotoxic Agents. Oncology 57(Suppl 1): 9-15
Blum, J.L. 1999: Xeloda in the Treatment of Metastatic Breast Cancer. Oncology 57(1): 16-20
Marty, M.; Espie, M.; Cottu, P.H.; Cuvier, C.; Lerebours, F. 1999: Optimizing Chemotherapy for Patients with Advanced Breast Cancer. Oncology 57(1): 21-26
Cassidy, J. 1999: Potential of Xeloda in Colorectal Cancer and Other Solid Tumors. Oncology 57(1): 27-32
Sato, B. 1999: Can an Autocrine Loop Explain Sex-Hormone-Dependent Tumor Growth?. Oncology 57(Suppl 2): 3-6
Harada, N. 1999: Aromatase and Intracrinology of Estrogen in Hormone-Dependent Tumors. Oncology 57(Suppl 2): 7-16
Saeki, T.; Takashima, S.; Tachibana, M.; Koga, M.; Hiyama, E.; Salomon, D.S.; Holland, J.F.; Ohnuma, T. 1999: Inhibitory Effect of Telomere-Mimic Phosphorothioate Oligodeoxy Nucleotides (S-Odns) on Human Tumor Cell Lines. Oncology 57(Suppl 2): 27-36
Maemura, M.; Iino, Y.; Koibuchi, Y.; Yokoe, T.; Morishita, Y. 1999: Mitogen-Activated Protein Kinase Cascade in Breast Cancer. Oncology 57(Suppl 2): 37-44
Matsuo, H.; Kurachi, O.; Shimomura, Y.; Samoto, T.; Maruo, T. 1999: Molecular Bases for the Actions of Ovarian Sex Steroids in the Regulation of Proliferation and Apoptosis of Human Uterine Leiomyoma. Oncology 57(Suppl 2): 49-58
Fujimoto, J.; Sakaguchi, H.; Misao, R.; Hirose, R.; Wen, H.; Tamaya, T. 1999: Progestin Regulation in Tumor Growth of Female Genital Tract Cancers. Oncology 57(Suppl 2): 59-63
Terakawa, N. 2000: Approaches Targeted to Estrogen Receptors for Treatment of Tamoxifen-Resistant Breast Cancer: A Brief Overview. Oncology 59(Suppl 1): 3-4
Sasano, H.; Suzuki, T.; Takeyama, J.; Utsunomiya, H.; Ito, K.; Ariga, N.; Moriya, T. 2000: 17-Beta-Hydroxysteroid Dehydrogenase in Human Breast and Endometrial Carcinoma. Oncology 59(Suppl 1): 5-12
Tanaka, H.; Makino, Y.; Okamoto, K.; Iida, T.; Yoshikawa, N.; Miura, T. 2000: Redox Regulation of the Nuclear Receptor. Oncology 59(Suppl 1): 13-18
Kimijima, I.; Ohtake, T.; Sagara, H.; Watanabe, T.; Takenoshita, S. 2000: Scattered Fat Invasion: An Indicator for Poor Prognosis in Premenopausal, and for Positive Estrogen Receptor in Postmenopausal Breast Cancer Patients. Oncology 59(Suppl 1): 25-30
Kurebayashi, J.; Sonoo, H.; Inaji, H.; Nishimura, R.; Iino, Y.; Toi, M.; Kobayashi, S.; Saeki, T. 2000: Endocrine Therapies for Patients with Recurrent Breast Cancer: Predictive Factors for Responses to First- and Second-Line Endocrine Therapies. Oncology 59(Suppl 1): 31-37
Yano, T.; Radulovic, S.; Osuga, Y.; Kugu, K.; Yoshikawa, H.; Taketani, Y.; Schally, A.V. 2000: Inhibition of Human Epithelial Ovarian Cancer Cell Growth in vitro by Somatostatin Analog Rc-160. Oncology 59(Suppl 1): 45-49
Greggi, S.; Salerno, M.G.; D'Agostino, G.; Ferrandina, G.; Lorusso, D.; Manzione, L.; Mancuso, S.; Scambia, G. 2000: Topotecan and Gemcitabine in Platinum/Paclitaxel-Resistant Ovarian Cancer. Oncology 60(1): 19-23
Polgár, C.; Orosz, Z.; Szerdahelyi, A.; Fodor, J.; Major, T.; Mágori, A.; Czeyda-Pommersheim, F.; Vámosi Nagy, I.; Szakolczai, I.; Fejös, Z.; Németh, G. 2000: Postirradiation Angiosarcoma of the Chest Wall and Breast: Issues of Radiogenic Origin, Diagnosis and Treatment in Two Cases. Oncology 60(1): 31-34
Nohara, T.; Ryo, T.; Iwamoto, S.; Gon, G.; Tanigawa, N. 2000: Expression of Cell-Cycle Regulator p27 Is Correlated to the Prognosis and Er Expression in Breast Carcinoma Patients. Oncology 60(1): 94-100
Schiller, J.H. 2001: Novel Therapies in Lung Cancer Management. Oncology 61(1): 1-2
Schiller, J.H. 2001: Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer. Oncology 61(Suppl 1): 3-13
Huang, C.H.; Treat, J. 2001: New Advances in Lung Cancer Chemotherapy: Topotecan and the Role of Topoisomerase I Inhibitors. Oncology 61(1): 14-24
O'Neill, P.; Clark, P.I.; Smith, D.; Marshall, E.; Hannigan, K.; Ross, G. 2001: A Phase I Trial of a 5-Day Schedule of Intravenous Topotecan and Etoposide in Previously Untreated Patients with Small-Cell Lung Cancer. Oncology 61(1): 25-29
Eckardt, J.R. 2001: Feasibility of Oral Topotecan Plus Intravenous Paclitaxel in Advanced Non-Small-Cell Lung Cancer. Oncology 61(1): 30-34
Stupp, R.; Bodmer, A.; Duvoisin, B.; Bauer, J.; Perey, L.; Bakr, M.; Ketterer, N.; Leyvraz, S. 2001: Is Cisplatin Required for the Treatment of Non-Small-Cell Lung Cancer? Experience and Preliminary Results of a Phase I/Ii Trial with Topotecan and Vinorelbine. Oncology 61(Suppl 1): 35-41
Schiller, J.H. 2001: Future Role of Topotecan in the Treatment of Lung Cancer. Oncology 61(1): 55-59
Baselga, J.é , 2001: Herceptin ® Alone or in Combination with Chemotherapy in the Treatment of Her2-Positive Metastatic Breast Cancer: Pivotal Trials. Oncology 61(Suppl 2): 14-21
Hanna, W. 2001: Testing for Her2 Status. Oncology 61(Suppl 2): 22-30
Leyland-Jones, B. 2001: Dose Scheduling – Herceptin ®. Oncology 61(Suppl 2): 31-36
Vogel, C.L.; Cobleigh, M.A.; Tripathy, D.; Gutheil, J.C.; Harris, L.N.; Fehrenbacher, L.; Slamon, D.J.; Murphy, M.; Novotny, W.F.; Burchmore, M.; Shak, S.; Stewart, S.J. 2001: First-Line Herceptin ® Monotherapy in Metastatic Breast Cancer. Oncology 61(Suppl 2): 37-42
Diéras, V.; Beuzeboc, P.; Laurence, V.; Pierga, J.Y.; Pouillart, P. 2001: Interaction between Herceptin and Taxanes. Oncology 61(2): 43-49
Winer, E.P.; Burstein, H.J. 2001: New Combinations with Herceptin in Metastatic Breast Cancer. Oncology 61(2): 50-57
Cook-Bruns, N. 2001: Retrospective Analysis of the Safety of Herceptin ® Immunotherapy in Metastatic Breast Cancer. Oncology 61(Suppl 2): 58-66
Mé, M.é nard, S.; Fortis, S.; Castiglioni, F.; Agresti, R.; Balsari, A. 2001: Her2 as a Prognostic Factor in Breast Cancer. Oncology 61(Suppl 2): 67-72
Piccart, M.; Lohrisch, C.; DiLeo, A.; Larsimont, D. 2001: The Predictive Value of Her2 in Breast Cancer. Oncology 61(Suppl 2): 73-82
Leyland-Jones, B.; Smith, I. 2001: Role of Herceptin ® in Primary Breast Cancer: Views from North America and Europe. Oncology 61(Suppl 2): 83-91
Sabetti, L.; Specchia, G.; Toscano, A.; Balestrazzi, E. 1998: Biometric Pre-Operative Evaluation of Ocular Axial Length in Patients Subjected to Corneal Transplantation. Ophthalmologica 212(1): 30-32
Mantovani, E.; Doro, D.; Milizia, E.; Steindler, P. 1998: Recurrent Eyelid Basal Cell Carcinoma with Sclerochoroidal Infiltration: Echographic Findings. Ophthalmologica 212(1): 40-41
Bacchetti, S.; Bressan, P.; Della Mea, G. 1998: Melanoma of the Choroid above the Optic Disc: Considerations Concerning a Clinical Case. Ophthalmologica 212(1): 53-56
Mancini, A.; Colangelo, L.; Lapi, G.; Lobefalo, L.; Ciancaglini, M.; Mastropasqua, L.; Gallenga, P.E. 1998: A Case of Quiescent Choroidal Melanoma: Early Echographic Signs of Reactivation. Ophthalmologica 212(1): 57-60
Gallenga, P.E.; Mancini, A.; DiBastiano, W.; Colangelo, L.; Carpineto, P.; Lobefalo, L. 1998: Congenital Retinoblastoma: Appearance of Calcifications during Short-Term Follow-Up. Ophthalmologica 212(1): 61-64
Sabetti, L.; Specchia, G.; Toscano, A.; Balestrazzi, E. 1998: Echographic Follow-Up in Patients Who Have Undergone Sclero-Uveotumorectomy. Ophthalmologica 212(1): 65-67
Specchia, G.; Balestrazzi, E. 1998: Evaluation of the Echographic Contribution to the Parasurgical Treatment of Melanomas of Small Dimensions. Ophthalmologica 212(1): 68-70
Ghosh, F.; Bruun, A.; Ehinger, B. 1999: Immunohistochemical Markers in Full-Thickness Embryonic Rabbit Retinal Transplants. Ophthalmic Research 31(1): 5-15
Sasaki, H.; Hockwin, O.; Kasuga, T.; Nagai, K.; Sakamoto, Y.; Sasaki, K. 1999: An Index for Human Lens Transparency Related to Age and Lens Layer: Comparison between Normal Volunteers and Diabetic Patients with Still Clear Lenses. Ophthalmic Research 31(2): 93-103
Sharma, R.K. 2000: Developmental Expression of Gaba A Receptors in Retinal Transplants. Ophthalmic Research 32(2-3): 45-51
Peters, S.; Kayatz, P.; Heimann, K.; Schraermeyer, U. 2000: Subretinal Injection of Rod Outer Segments Leads to an Increase in the Number of Early-Stage Melanosomes in Retinal Pigment Epithelial Cells. Ophthalmic Research 32(2-3): 52-56
Moriarty, P.; Dickson, A.J.; Erichsen, J.T.; Boulton, M. 2000: Protein Kinase C Isoenzyme Expression in Retinal Cells. Ophthalmic Research 32(3): 57-60
Pinazo-Durán, M.D.; Verdejo, C.; Azorín, I.; Renau-Piqueras, J.; Iborra, F.J. 2000: Colocalization of Aldehyde Dehydrogenases and Fe/Nadph-Induced Lipid Peroxidation in Tissue Sections of Rat Retina. Ophthalmic Research 32(2-3): 61-68
Nomura, R.; Terasaki, H.; Hirose, H.; Miyake, Y. 2000: Blue-on-Yellow Perimetry to Evaluate S Cone Sensitivity in Diabetics. Ophthalmic Research 32(2-3): 69-72
Bardak, Y.; Çekiç, O.; Ayhan, A.; Günalp, İlhan; Bulay, O. 2000: Nucleoside Diphosphate Kinase (nm23 Protein) Expression in Retinoblastoma. Ophthalmic Research 32(2-3): 73-78
Sugiyama, T.; Schwartz, B.; Takamoto, T.; Azuma, I. 2000: Evaluation of the Circulation in the Retina, Peripapillary Choroid and Optic Disk in Normal-Tension Glaucoma. Ophthalmic Research 32(2-3): 79-86
Trimborn, M.; Iwig, M.; Glanz, D.; Gruner, M.; Glaesser, D. 2000: Linoleic Acid Cytotoxicity to Bovine Lens Epithelial Cells: Influence of Albumin on Linoleic Acid Uptake and Cytotoxicity. Ophthalmic Research 32(2-3): 87-93
Kurosaka, D.; Kato, K.; Oshima, T.; Kurosaka, H.; Yoshino, M.; Nagamoto, T. 2000: Effect of Rabbit Aqueous Humor Obtained after Cataract Surgery on Collagen Gel Contraction Induced by Bovine Lens Epithelial Cells. Ophthalmic Research 32(2-3): 94-99
Bian, L.; Zeng, J.; Borchman, D.; Paterson, C.A. 2000: Plasma Membrane Calcium Atpase Gene Expression in Bovine Lens Epithelium. Ophthalmic Research 32(3): 100-105
Er, H.; Gündüz, A.; Cigli, A.; Turkoz, Y.; Cekmen, M. 2000: Quantification of Nitric Oxide and Cytokines in Rabbit Aqueous Humor after Neodymium:Yag Laser Capsulotomy. Ophthalmic Research 32(2-3): 106-109
Korobelnik, J.F.; D'Hermies, F.; Chauvaud, D.; Legeais, J.M.; Hoang-Xuan, T.; Renard, G. 2000: Expanded Polytetrafluoroethylene Episcleral Implants Used as Encircling Scleral Buckling. Ophthalmic Research 32(2-3): 110-117
Wutzler, P.; Sauerbrei, A.; Klöcking, R.; Burkhardt, J.; Schacke, M.; Thust, R.; Fleischer, W.; Reimer, K. 2000: Virucidal and Chlamydicidal Activities of Eye Drops with Povidone-Iodine Liposome Complex. Ophthalmic Research 32(2-3): 118-125
Karaküçük, S.; Mirza, E.ǧrul; Sümerkan, B.; Okten, T. 2000: Intravitreal Trovafloxacin against Experimental Staphylococcus epidermidis Endophthalmitis. Ophthalmic Research 32(2-3): 126-131
Mirshahi, M.; Mirshahi, S.; Golestaneh, N.; Nicolas, C.; Mishal, Z.; Lounes, K.C.; Hecquet, C.; Dagonet, F.; Pouliquen, Y.; Agarwal, M.K. 2001: Mineralocorticoid Hormone Signaling Regulates the Epithelial Sodium Channel in Fibroblasts from Human Cornea. Ophthalmic Research 33(1): 7-19
Weale, R.A. 2001: Arm A New Disease or a New Discovery?. Ophthalmic Research 33(2): 123-124
Billante, C.R.; Burkard, K.A.; Clary, J.M.; Childs, P.; Netterville, J.L. 2001: Voice Outcome following Lateral Laryngotomy to Remove Teflon Granuloma. Orl 63(5): 302-306
Plasswilm, L.; Tannapfel, A.; Cordes, N.; Demir, R.; Höper, K.; Bauer, J.; Höper, J. 2001: Hypoxia-Induced Tumour Cell Migration in an in vivo Chicken Model. Pathobiology 68(3): 99-105
Gebken, J.; Brenner, R.; Feydt, A.; Notbohm, H.; Brinckmann, J.; Müller, P.K.; Bätge, B. 2001: Increased Cell Surface Expression of Receptors for Transforming Growth Factor- on Osteoblasts from Patients with Osteogenesis imperfecta. Pathobiology 68(3): 106-112
Stoehr, R.; Hartmann, A.; Hiendlmeyer, E.; Mü, M.ü rle, K.; Wieland, W.; Knuechel, R. 2000: Oligoclonality of Early Lesions of the Urothelium as Determined by Microdissection-Supported Genetic Analysis. Pathobiology 68(4-5): 165-172
Glö, G.ö ckner, S.; Lehmann, U.; Wilke, N.; Kleeberger, W.; Lä, L.ä nger, F.; Kreipe, H. 2000: Detection of Gene Amplification in Intraductal and Infiltrating Breast Cancer by Laser-Assisted Microdissection and Quantitative Real-Time Pcr. Pathobiology 68(4-5): 173-179
Wild, P.; Knuechel, R.; Dietmaier, W.; Hofstaedter, F.; Hartmann, A. 2000: Laser Microdissection and Microsatellite Analyses of Breast Cancer Reveal a High Degree of Tumor Heterogeneity. Pathobiology 68(4-5): 180-190
Bohle, R.M.; Hartmann, E.; Kinfe, T.; Ermert, L.; Seeger, W.; Fink, L. 2000: Cell Type-Specific mRna Quantitation in Non-Neoplastic Tissues after Laser-Assisted Cell Picking. Pathobiology 68(4-5): 191-195
Kleeberger, W.; Rothämel, T.; Glöckner, S.; Lehmann, U.; Kreipe, H. 2000: Laser-Assisted Microdissection and Short Tandem Repeat Pcr for the Investigation of Graft Chimerism after Solid Organ Transplantation. Pathobiology 68(4-5): 196-201
Lehmann, U.; Bock, O.; Glö, G.ö ckner, S.; Kreipe, H. 2000: Quantitative Molecular Analysis of Laser-Microdissected Paraffin- Embedded Human Tissues. Pathobiology 68(4-5): 202-208
Fend, F.; Kremer, M.; Quintanilla-Martinez, L. 2000: Laser Capture Microdissection: Methodical Aspects and Applications with Emphasis on Immuno-Laser Capture Microdissection. Pathobiology 68(4-5): 209-214
Ren, Z.-P.; Sä, S.ä llströ, llströ m, J.; Sundströ, S.ö m, C.; Nisté, N.é r, M.; Olsson, Y. 2000: Recovering Dna and Optimizing Pcr Conditions from Microdissected Formalin-Fixed and Paraffin-Embedded Materials. Pathobiology 68(4-5): 215-217
Lahr, G.; Stich, M.; Schütze, K.; Blümel, P.; Pösl, H.; Nathrath, W.B.J. 2000: Diagnosis of Papillary Thyroid Carcinoma Is Facilitated by Using an Rt-Pcr Approach on Laser-Microdissected Archival Material to Detect Ret Oncogene Activation. Pathobiology 68(4-5): 218-226
Dietmaier, W.; Gänsbauer, S.; Beyser, K.; Renke, B.; Hartmann, A.; Rümmele, P.; Jauch, K.-W.; Hofstädter, F.; Rüschoff, J. 2000: Microsatellite Instability in Tumor and Nonneoplastic Colorectal Cells from Hereditary Non-Polyposis Colorectal Cancer and Sporadic High Microsatellite-Instable Tumor Patients. Pathobiology 68(4-5): 227-231
Clement-Sengewald, A.; Buchholz, T.; Schütze, K. 2000: Laser Microdissection as a New Approach to Prefertilization Genetic Diagnosis. Pathobiology 68(4-5): 232-236
Furuya, M.; Ishikura, H.; Ogawa, Y.; Kawarada, Y.; Shibata, M.; Fujimoto, S.; Yoshiki, T. 2000: Analyses of Matrix Metalloproteinases and Their Inhibitors in Cyst Fluid of Serous Ovarian Tumors. Pathobiology 68(6): 239-244
Makala, L.H.C.; Kamada, T.; Nishikawa, Y.; Nagasawa, H.; Igarashi, I.; Fujisaki, K.; Suzuki, N.; Mikami, T.; Haverson, K.; Bailey, M.; Stokes, C.R.; Bland, P.W. 2000: Ontogeny of Pig Discrete Peyers Patches: Distribution and Morphometric Analysis. Pathobiology 68(6): 275-282
Middel, P.; Lippert, U.; Hummel, K.M.; Bertsch, H.P.; Artuc, M.; Schweyer, S.; Radzun, H.-J. 2000: Expression of Lymphotoxin- by Keratinocytes: A Further Mediator for the Lichenoid Reaction. Pathobiology 68(6): 291-300
Stoy, N. 2001: Macrophage Biology and Pathobiology in the Evolution of Immune Responses: A Functional Analysis. Pathobiology 69(4): 179-211
Gogiel, T.; Ba&nacute, B.ń kowski, E.; Jaworski, S. 2001: Pre-Eclampsia-Associated Differential Expression of Proteoglycans in the Umbilical Cord Arteries. Pathobiology 69(4): 212-218
Shaish, A.; Keren, G.; Chouraqui, P.; Levkovitz, H.; Harats, D. 2001: Imaging of Aortic Atherosclerotic Lesions by 125 I-Ldl, 125 I-Oxidized-Ldl, 125 I-Hdl and 125 I-Bsa. Pathobiology 69(4): 225-229
García de Galdeano, A.; Cruz-Conde, J.C.; Boyano, M.D.; García-Vázquez, M.D.; Cañavate, M.L. 2001: Effect of Il-2 and Il-6 on Parameters Related to Metastatic Activity in a Murine Melanoma. Pathobiology 69(4): 230-236
Pillai, S.; Praharaj, S.S.; Mohanty, A.; Kolluri, V.R.S. 2001: Prognostic Factors in Children with Severe Diffuse Brain Injuries: A Study of 74 Patients. Pediatric Neurosurgery 34(2): 98-103
Stone, J. 2001: Orville T. Bailey, Md. Pediatric Neurosurgery 34(5): 226-228
Horinouchi, T.; Yamamoto, Y.; Koike, K. 2001: Effect of Sr59230A on Atypical -Adrenoceptor Mediating Relaxation in the Guinea Pig Gastric Fundus. Pharmacology 62(2): 98-102
Ahn, B.O.; Kim, K.H.; Lee, G.; Lee, H.S.; Kim, C.D.; Kim, Y.S.; Son, M.W.; Kim, W.B.; Oh, T.Y.; Hyun, J.H. 2008: Effects of Taurine on Cerulein-Induced Acute Pancreatitis in the Rat. Pharmacology 63(1): 1-7
Chang, F.-Y.; Lu, C.-L.; Chen, C.-Y.; Lee, S.-D.; Tsai, D.-S.; Fu, S.-E. 2008: The Pharmacological Effect of Omeprazole on Water Gastric Emptying: A Study Based on an Impedance Measure. Pharmacology 63(1): 50-57
Tsukamoto, K.; Tagi, Y.; Nakazawa, T.; Takeda, M. 2001: Gastroprokinetic Effect and Mechanism of Sk-896, a New Motilin Analogue, during the Interdigestive Period in Conscious Dogs. Pharmacology 63(2): 95-102
Malatynska, E.; Goldenberg, R.; Shuck, L.; Haque, A.; Zamecki, P.; Crites, G.; Schindler, N.; Knapp, R.J. 2002: Reduction of Submissive Behavior in Rats: A Test for Antidepressant Drug Activity. Pharmacology 64(1): 8-17
Khan, I.; Hussein, S.M.K.; Oriowo, M.A. 2002: Studies on the Expression and Function of Beta-3-Adrenoceptors in the Colon of Rats with Acetic Acid-Induced Colitis. Pharmacology 64(2): 98-105
Choppin, A.; Groke, G.; Bringas, A.; Stepan, G.; Dillon, M.P. 2002: Effect of Ym-44781, Ym-44778 and Ym-49598, Novel Tachykinin Antagonists, in a Drug-Induced Bladder Contraction Model. Pharmacology 65(2): 96-102
Albert, U.; Maina, G.; Ravizza, L.; Bogetto, F. 2002: An Exploratory Study on Obsessive-Compulsive Disorder with and without a Familial Component: Are There Any Phenomenological Differences?. Psychopathology 35(1): 8-16
Labbate, L.A.; Lare, S.B. 2001: Sexual Dysfunction in Male Psychiatric Outpatients: Validity of the Massachusetts General Hospital Sexual Functioning Questionnaire. Psychotherapy and Psychosomatics 70(4): 221-225
Fava, G.A.; Ottolini, F.; Sonino, N. 2001: Which Are the Leading Countries in Clinical Medicine Research? A Citation Analysis (19811998). Psychotherapy and Psychosomatics 70(6): 283-287
Trikas, P.; Vlachonikolis, I.; Samonis, G.; Askoxilakis, I.; Tsiftsis, D.; Koutsoubi, K.; Paritsis, N. 2002: Low Psychopathology Scores in the Prognosis of Breast Cancer. Psychotherapy and Psychosomatics 71(3): 162-167
Hodson, M.E. 2000: Treatment of Cystic Fibrosis in the Adult. Respiration 67(6): 595-607
Müller, K.M.; Fischer, M. 2000: Malignant Pleural Mesotheliomas: An Environmental Health Risk in Southeast Turkey. Respiration 67(6): 608-609
Şenyiğit, A.; Babayiğit, C.; Gökirmak, M.; Topçu, F.; Asan, E.; Coşkunsel, M.; Işık, R.; Ertem, M. 2000: Incidence of Malignant Pleural Mesothelioma due to Environmental Asbestos Fiber Exposure in the Southeast of Turkey. Respiration 67(6): 610-614
Şenyiğit, A.; Bayram, H.; Babayiğit, C.; Topçu, F.; Nazaroğlu, H.; Bilici, A.; Leblebici, i.H. 2000: Malignant Pleural Mesothelioma Caused by Environmental Exposure to Asbestos in the Southeast of Turkey: Ct Findings in 117 Patients. Respiration 67(6): 615-622
Şenyiğit, A.; Bayram, H.; Babayiğit, C.; Topçu, F.; Balci, A.ınE.; Satici, . 2000: Comparison of the Effectiveness of Some Pleural Sclerosing Agents Used for Control of Effusions in Malignant Pleural Mesothelioma: A Review of 117 Cases. Respiration 67(6): 623-629
Riedel, M.; Stein, H.J.; Mounyam, L.; Busch, R.; Siewert, J.R. 2000: Predictors of Tracheobronchial Invasion of Suprabifurcal Oesophageal Cancer. Respiration 67(6): 630-637
Muro, S.; Nakano, Y.; Sakai, H.; Takubo, Y.; Oku, Y.; Chin, K.; Nishimura, K.; Hirai, T.; Kawakami, K.; Nakamura, T.; Mishima, M. 2000: Distorted Trachea in Patients with Chronic Obstructive Pulmonary Disease. Respiration 67(6): 638-644
Tsujino, I.; Nishimura, M.; Kamachi, A.; Makita, H.; Munakata, M.; Miyamoto, K.; Kawakami, Y. 2000: Exhaled Nitric Oxide Is It Really a Good Marker of Airway Inflammation in Bronchial Asthma?. Respiration 67(6): 645-651
Aizawa, H.; Inoue, H.; Miyazaki, N.; Hara, N. 2000: Histamine-Induced Increase in Isometric Tension of Smooth Muscle Is Mediated by Local Vagus Nerve in Human Bronchus. Respiration 67(6): 652-656
Couturaud, F.; Oger, E.; Abalain, J.H.; Chenu, E.; Guias, B.; Floch, H.H.; Mercier, B.; Mottier, D.; Leroyer, C. 2000: Methylenetetrahydrofolate Reductase C677T Genotype and Venous Thromboembolic Disease. Respiration 67(6): 657-661
Aihara, M.; Dobashi, K.; Akiyama, M.; Naruse, I.; Nakazawa, T.; Mori, M. 2000: Effects of N-Acetylcysteine and Ambroxol on the Production of Il-12 and Il-10 in Human Alveolar Macrophages. Respiration 67(6): 662-671
van Noord, J.A.; Smeets, J.J.; Creemers, J.P.H.M.; Greefhorst, L.P.M.; Dewberry, H.; Cornelissen, P.J.G. 2000: Delivery of Fenoterol via Respimat ® , a Novel ‘Soft Mist’ Inhaler. Respiration 67(6): 672-678
Briasoulis, E.; Froudarakis, M.; Milionis, H.J.; Peponis, I.; Constantopoulos, S.; Pavlidis, N. 2000: Chemotherapy-Induced Noncardiogenic Pulmonary Edema Related to Gemcitabine plus Docetaxel Combination with Granulocyte Colony-Stimulating Factor Support. Respiration 67(6): 680-683
Woo, P.C.Y.; Young, K.; Tsang, K.W.T.; Ooi, C.G.C.; Peiris, M.; Yuen, K. 2000: Adult Croup: A Rare but More Severe Condition. Respiration 67(6): 684-688
Arriero, J.M.; Chiner, E.; Signes-Costa, J.; Marco, J.; Cañizares, R.; Mayol, M.J.; Onrubia, J.A. 2000: Chronic Alveolar Consolidation and Watery Sputum in an Elderly Woman. Respiration 67(6): 693-695
Oymak, S.F.; Gülmez, İnci; Demir, R.; Özesmi, M. 2000: Transmission of Mycobacterium tuberculosis by Accidental Needlestick. Respiration 67(6): 696-697
Etter, J.-F.ç ois, ois 2002: Using New Information Technology to Treat Tobacco Dependence. Respiration 69(2): 111-114
Cherniack, N.S. 2002: Singing the Chronic Obstructive Pulmonary Disease Blues. Respiration 69(2): 115-116
Sergi, M.; Rizzi, M.; Andreoli, A.; Pecis, M.; Bruschi, C.; Fanfulla, F. 2002: Are Copd Patients with Nocturnal Rem Sleep-Related Desaturations More Prone to Developing Chronic Respiratory Failure Requiring Long-Term Oxygen Therapy?. Respiration 69(2): 117-122
Hardie, J.A.; Mø, M.ø rkve, O.; Ellingsen, I. 2002: Effect of Body Position on Arterial Oxygen Tension in the Elderly. Respiration 69(2): 123-128
Prieto, L.; Sánchez-Toril, F.; Gutiérrez, V.; Marín, M.J. 2002: Airway Responsiveness to Inhaled Acetaldehyde in Subjects with Allergic Rhinitis: Relationship to Methacholine Responsiveness. Respiration 69(2): 129-135
Ferreira, A.; Williams, Z.; Donninger, H.; van Schalkwyk, E.M.; Bardin, P.G. 2002: Rhinovirus Is Associated with Severe Asthma Exacerbations and Raised Nasal Interleukin-12. Respiration 69(2): 136-142
Shih, C.-M.; Shiau, Y.-C.; Wang, J.J.; Ho, S.-T.; Kao, A. 2002: Increased Lung Uptake of Technetium-99m Hexamethylpropylene Amine Oxime in Systemic Lupus erythematosus. Respiration 69(2): 143-147
Kunisawa, A.; Kawanishi, Y.; Tago, H.; Nagate, A.; Kasuga, I.; Ohyashiki, K. 2002: Direct Demonstration of the Productive Capability of Cytokines at the Single Cell Level in Lung Sarcoidosis Using Multicolor Cytometry. Respiration 69(2): 155-164
Wong, C.F.; Fung, S.L.; Yew, W.W.; Fu, K.H. 2002: A Case of Malignant Pleural Mesothelioma with Unexpectedly Long Survival without Active Treatment. Respiration 69(2): 166-168
Verbraecken, J.; Willemen, M.; de Cock, W.; Van de Heyning, P.; de Backer, W. 2002: Intermittent Positive Airway Pressure by Nasal Mask as a Treatment for Respiratory Insufficiency in a Patient with Syringomyelia. Respiration 69(2): 169-174
Asano, T.; Itoh, G.; Itoh, M. 2002: Disseminated Mycobacterium intracellulare Infection in an Hiv-Negative, Nonimmunosuppressed Patient with Multiple Endobronchial Polyps. Respiration 69(2): 175-177
Aktogu, S.; Erer, O.F.; Ürpek, G.; Soy, .; Tibet, G. 2002: Multiple Pulmonary Arterial Aneurysms in Behets Disease: Clinical and Radiologic Remission after Cyclophosphamide and Corticosteroid Therapy. Respiration 69(2): 178-181
Del Grande, F.; Russi, E.W.; Hailemariam, S.; Hauser, M. 2002: Extensive Tracheobronchial Wall Thickening and Luminal Narrowing in a Patient with Longstanding Hoarseness. Respiration 69(2): 186-190
Zhai, H.; Maibach, H.I. 2001: Effects of Skin Occlusion on Percutaneous Absorption: An Overview. Skin Pharmacology and Physiology 14(1): 1-10
Kim, J.; Hwang, J.-S.; Cho, Y.-K.; Han, Y.; Jeon, Y.-J.; Yang, K.-H. 2001: Protective Effects of ()-Epigallocatechin-3-Gallate on Uva- and Uvb-Induced Skin Damage. Skin Pharmacology and Physiology 14(1): 11-19
Kynemund, L.; Jemec, G.B.E.; Wulf, H.C. 2001: Moisturisers for Psoriatic Skin Do Gross Morphological Differences Matter?. Skin Pharmacology and Physiology 14(1): 20-26
Hagströmer, L.; Nyrén, M.; Emtestam, L. 2001: Do Urea and Sodium Chloride together Increase the Efficacy of Moisturisers for Atopic Dermatitis Skin?. Skin Pharmacology and Physiology 14(1): 27-33
Gloor, M.; Haus, C.; Fluhr, J.W.; Gehring, W. 2001: Do Shake Lotions, Zinc Oil and Polyethylene Glycol Gels Produce Dehydration or Moisturization?. Skin Pharmacology and Physiology 14(1): 34-43
Stücker, M.; Steinberg, J.; Memmel, U.; Avermaete, A.; Hoffmann, K.; Altmeyer, P. 2001: Differences in the Two-Dimensionally Measured Laser Doppler Flow at Different Skin Localisations. Skin Pharmacology and Physiology 14(1): 44-51
Ahmad, N.; Mukhtar, H. 2001: Cutaneous Photochemoprotection by Green Tea: A Brief Review. Skin Pharmacology and Physiology 14(2): 69-76
Camarasa, J.M.G.; Aliaga, A.; Fernández-Vozmediano, J.M.; Fonseca, E.; Iglesias, L.; Tagarro, I. 2001: Azelastine Tablets in the Treatment of Chronic Idiopathic Urticaria. Skin Pharmacology and Physiology 14(2): 77-86
Inagaki, N.; Nagao, M.; Igeta, K.; Kawasaki, H.; Kim, J.F.; Nagai, H. 2001: Scratching Behavior in Various Strains of Mice. Skin Pharmacology and Physiology 14(2): 87-96
Doliwa, A.; Santoyo, S.; Ygartua, P. 2001: Influence of Piroxicam: Hydroxypropyl-Beta-Cyclodextrin Complexation on the in vitro Permeation and Skin Retention of Piroxicam. Skin Pharmacology and Physiology 14(2): 97-107
Cantürk, N.Z.; Esen, N.; Vural, B.; Cantürk, Z.; Kirkali, G.; Oktay, G.; Solakoglu, S. 2001: The Relationship between Neutrophils and Incisional Wound Healing. Skin Pharmacology and Physiology 14(2): 108-116
Rogiers, V. 2001: Eemco Guidance for the Assessment of Transepidermal Water Loss in Cosmetic Sciences. Skin Pharmacology and Physiology 14(2): 117-128
Fischer, T.W.; Wigger-Alberti, W.; Elsner, P. 2001: Assessment of Dry Skin: Current Bioengineering Methodsa nd Test Designs. Skin Pharmacology and Physiology 14(4): 183-195
Hikima, T.; Maibach, H.I. 2001: Distribution of Hydrolytic Activity Catalyzes the Biotransformation of Prednisolone 21-Acetate in Human Skin. Skin Pharmacology and Physiology 14(4): 196-202
Hikima, T.; Ohno, Y.; Maibach, H.I. 2001: Metabolism of Prednisolone 21-Acetate in Hairless Mouse Skin. Skin Pharmacology and Physiology 14(4): 203-209
Neumann, N.J.; Grosse, O.J.; Ruzicka, T.; Lehmann, P. 2001: Penetration Kinetics of 8-Methoxypsoralen after 8-Methoxypsoralen Bath Procedure with and without Uva Irradiation. Skin Pharmacology and Physiology 14(4): 210-216
Bonnekoh, B.; Bö, B.ö ckelmann, R.; Ambach, A.; Gollnick, H. 2001: Dithranol and Dimethylfumarate Suppress the Interferon-γ-Induced Up-Regulation of Cytokeratin 17 as a Putative Psoriasis Autoantigen in vitro. Skin Pharmacology and Physiology 14(4): 217-225
Fukuoka, M.; Sakurai, K.; Ohta, T.; Kiyoki, M.; Katayama, I. 2001: Tacalcitol, an Active Vitamin D 3 , Induces Nerve Growth Factor Production in Human Epidermal Keratinocytes. Skin Pharmacology and Physiology 14(4): 226-233
Portalè, P.è s, P.; Ariè, A.è s, M.-F.; Licu, D.; Pinton, J.; Hernandez-Pion, C.; Gall, Y.; Dupuy, P.; Charveron, M.; Clot, J. 2001: Immunomodulation Induced by Avène Spring Water on Th1- and Th2-Dependent Cytokine Production in Healthy Subjects and Atopic Dermatitis Patients. Skin Pharmacology and Physiology 14(4): 234-242
Ambach, A.; Bonnekoh, B.; Gollnick, H. 2001: Perforin Granule Release from Cytotoxic Lymphocytes ex vivo Is Inhibited by Ciclosporin but Not by Methotrexate. Skin Pharmacology and Physiology 14(5): 249-260
Geilen, C.C.; Barz, S.; Bektas, M. 2001: Sphingolipid Signaling in Epidermal Homeostasis. Skin Pharmacology and Physiology 14(5): 261-271
Gratchev, A.; Schledzewski, K.; Guillot, P.; Goerdt, S. 2001: Alternatively Activated Antigen-Presenting Cells: Molecular Repertoire, Immune Regulation, and Healing. Skin Pharmacology and Physiology 14(5): 272-279
Kö, K.ö rbel, J.N.; Sebö, S.ö k, B.; Keré, K.é nyi, M.; Mahrle, G. 2001: Enhancement of the Antiparakeratotic Potency of Calcitriol and Tacalcitol in Liposomal Preparations in the Mouse Tail Test. Skin Pharmacology and Physiology 14(5): 291-295
Tebbe, B. 2001: Relevance of Oral Supplementation with Antioxidants for Prevention and Treatment of Skin Disorders. Skin Pharmacology and Physiology 14(5): 296-302
Zouboulis, C.C. 2001: Retinoids Which Dermatological Indications Will Benefit in the Near Future?. Skin Pharmacology and Physiology 14(5): 303-315
Schultz-Ehrenburg, U.; Blazek, V. 2001: Value of Quantitative Photoplethysmography for Functional Vascular Diagnostics. Skin Pharmacology and Physiology 14(5): 316-323
Stadler, R. 2001: Current Progress in Phlebosurgery. Skin Pharmacology and Physiology 14(5): 324-331
Tsambaos, D.; Badavanis, G. 2001: Skin Manifestations in Solid Organ Transplant Recipients. Skin Pharmacology and Physiology 14(5): 332-343
Hebert, J.L.; Khugyani, F.; Athar, M.; Kopelovich, L.; Epstein Jr., E.H.; Aszterbaum, M. 2001: Chemoprevention of Basal Cell Carcinomas in the ptc1 +/ Mouse Green and Black Tea. Skin Pharmacology and Physiology 14(6): 358-362
Sorg, O.; Tran, C.; Saurat, J.-H. 2001: Cutaneous Vitamins A and E in the Context of Ultraviolet- or Chemically-Induced Oxidative Stress. Skin Pharmacology and Physiology 14(6): 363-372
Elmets, C.A.; Katiyar, S.K.; Xu, H.; Mukhtar, H. 2001: Host Defense Mechanisms in Polyaromatic Hydrocarbon Carcinogenesis. Skin Pharmacology and Physiology 14(6): 386-392
Gutié, G.é rrez, P.P.; Kunitz, O.; Wolff, C.; Frank, J. 2001: Diagnosis and Treatment of the Acute Porphyrias: An Interdisciplinary Challenge. Skin Pharmacology and Physiology 14(6): 393-400
Krutmann, J. 2001: New Developments in Photoprotection of Human Skin. Skin Pharmacology and Physiology 14(6): 401-407
Hertl, M.; Veldman, C. 2001: Pemphigus – Paradigm of Autoantibody-Mediated Autoimmunity. Skin Pharmacology and Physiology 14(6): 408-418
Merk, H.F.; Sachs, B.; Baron, J. 2001: The Skin: Target Organ in Immunotoxicology of Small-Molecular-Weight Compounds. Skin Pharmacology and Physiology 14(6): 419-430
Corcuff, P.; Fiat, F.; Minondo, A.-M. 2004: Ultrastructure of the Human Stratum corneum. Skin Pharmacology and Physiology 14(1): 4-9
Lademann, J.; Otberg, N.; Richter, H.; Weigmann, H.-J.; Lindemann, U.; Schaefer, H.; Sterry, W. 2001: Investigation of Follicular Penetration of Topically Applied Substances. Skin Pharmacology and Physiology 14(Suppl 1): 17-22
Guy, R.H.; Delgado-Charro, M.B.; Kalia, Y.N. 2001: Iontophoretic Transport across the Skin. Skin Pharmacology and Physiology 14(Suppl 1): 35-40
Gautier, B.; Bernard, B.A. 2001: On the Use of Micro-Imager to Directly Visualize Drug Distribution in Human Skin. Skin Pharmacology and Physiology 14(1): 41-45
Cullander, C.; Grant, P.G.; Bench, G. 2001: Development of a Low-Metal Adhesive Tape to Detect and Localize Metals in or on the Stratum corneum at Parts per Million Levels. Skin Pharmacology and Physiology 14(1): 46-51
Bouwstra, J.; Pilgram, G.; Gooris, G.; Koerten, H.; Ponec, M. 2001: New Aspects of the Skin Barrier Organization. Skin Pharmacology and Physiology 14(Suppl 1): 52-62
Ponec, M.; Gibbs, S.; Pilgram, G.; Boelsma, E.; Koerten, H.; Bouwstra, J.; Mommaas, M. 2001: Barrier Function in Reconstructed Epidermis and Its Resemblance to Native Human Skin. Skin Pharmacology and Physiology 14(Suppl 1): 63-71
Hadgraft, J. 2001: Modulation of the Barrier Function of the Skin. Skin Pharmacology and Physiology 14(Suppl 1): 72-81
Kalia, Y.N.; Alberti, I.; Naik, A.; Guy, R.H. 2001: Assessment of Topical Bioavailability in vivo: The Importance of Stratum corneum Thickness. Skin Pharmacology and Physiology 14(Suppl 1): 82-86
Pflü, P.ü cker, F.; Wendel, V.; Hohenberg, H.; Gä, G.ä rtner, E.; Will, T.; Pfeiffer, S.; Wepf, R.; Gers-Barlag, H. 2001: The Human Stratum corneum Layer: An Effective Barrier against Dermal Uptake of Different Forms of Topically Applied Micronised Titanium Dioxide. Skin Pharmacology and Physiology 14(Suppl 1): 92-97
Weigmann, H.-J.; Lademann, J.; Schanzer, S.; Lindemann, U.; von Pelchrzim, R.; Schaefer, H.; Sterry, W.; Shah, V. 2001: Correlation of the Local Distribution of Topically Applied Substances Inside the Stratum corneum Determined by Tape-Stripping to Differences in Bioavailability. Skin Pharmacology and Physiology 14(Suppl 1): 98-102
Fukuoka, S.; Oka, K.; Seo, Y.; Tokanoshi, M.; Sumi, Y.; Nakamura, H.; Nakamura, J.; Ikawa, F. 1998: Apoptosis following Gamma Knife Radiosurgery in a Case of Acoustic Schwannoma. Stereotactic and Functional Neurosurgery 70(1): 88-94
Lim, Y.L.; Leem, W.; Kim, T.S.; Rhee, B.A.; Kim, G.K. 1998: Four Years Experiences in the Treatment of Pituitary Adenomas with Gamma Knife Radiosurgery. Stereotactic and Functional Neurosurgery 70(1): 95-109
Liščák, R.; Vladyka, V.; Šimonová, G.; Vymazal, J.; Janoušková, L. 1998: Leksell Gamma Knife Radiosurgery of the Tumor Glomus Jugulare and Tympanicum. Stereotactic and Functional Neurosurgery 70(1): 152-160
Bartolomei, F.; Massacrier, A.; Rey, M.; Viale, M.; Régis, J.; Gastaldi, M.; Cau, P. 1998: Effect of Gamma Knife Radiosurgery on Rat Brain Sodium Channel Subunit mRna Expression. Stereotactic and Functional Neurosurgery 70(1): 237-242
Cheung, J.Y.C.; Yu, C.P.; Ho, R.T.K. 1998: Tweaked Gamma Plan for Target Volume Measurement in Non-Fiducial Based Images: A Simple Routine for Follow-Up Assessment. Stereotactic and Functional Neurosurgery 70(1): 243-248
Kwon, Y.; Khang, S.K.; Kim, C.J.; Lee, D.J.; Lee, J.K.; Kwun, B.D. 1999: Radiologic and Histopathologic Changes after Gamma Knife Radiosurgery for Acoustic Schwannoma. Stereotactic and Functional Neurosurgery 72(Suppl 1): 2-10
Ré, R.é gis, Y.; Roberts, D.W. 1999: Gamma Knife Radiosurgery Relative to Microsurgery: Epilepsy. Stereotactic and Functional Neurosurgery 72(Suppl 1): 11-21
Bartolomei, F.; Régis, J.; Kida, Y.; Kobayashi, T.; Vladyka, V.; Liščàk, R.; Forster, D.M.C.; Kemeny, A.; Shrö, O.; Pendl, G. 1999: Gamma Knife Radiosurgery for Epilepsy Associated with Cavernous Hemangiomas: A Retrospective Study of 49 Cases. Stereotactic and Functional Neurosurgery 72(1): 22-28
Chang, J.W.; Kim, S.H.; Huh, R.; Park, Y.G.; Chung, S.S. 1999: The Effects of Stereotactic Radiosurgery on Secondary Facial Pain. Stereotactic and Functional Neurosurgery 72(1): 29-37
Kim, M.S.; Lee, S.I.; Sim, S.H. 1999: Brain Tumors with Cysts Treated with Gamma Knife Radiosurgery: Is Microsurgery Indicated?. Stereotactic and Functional Neurosurgery 72(1): 38-44
Jennelle, R.; Gladson, C.; Palmer, C.; Guthrie, B.; Markert, J. 1999: Paradoxical Labeling of Radiosurgically Treated Quiescent Tumors with Ki67, A Marker of Cellular Proliferation. Stereotactic and Functional Neurosurgery 72(1): 45-52
Leber, K.A.; Eustacchio, S.; Pendl, G. 1999: Radiosurgery of Glomus Tumors: Midterm Results. Stereotactic and Functional Neurosurgery 72(1): 53-59
Vermeulen, S.; Young, R.; Li, F.; Meier, R.; Raisis, J.; Klein, S.; Kohler, E. 1999: A Comparison of Single Fraction Radiosurgery Tumor Control and Toxicity in the Treatment of Basal and Nonbasal Meningiomas. Stereotactic and Functional Neurosurgery 72(1): 60-66
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1999: Low-Dose Radiosurgery for Meningiomas. Stereotactic and Functional Neurosurgery 72(1): 67-72
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1999: Gamma Knife Radiosurgery for Metastatic Brain Tumor: The Usefulness of Repeated Gamma Knife Radiosurgery for Recurrent Cases. Stereotactic and Functional Neurosurgery 72(1): 73-80
Mokry, M.; Ramschak-Schwarzer, S.; Simbrunner, J.; Ganz, J.C.; Pendl, G. 1999: A Six Year Experience with the Postoperative Radiosurgical Management of Pituitary Adenomas. Stereotactic and Functional Neurosurgery 72(1): 88-100
Kim, S.H.; Huh, R.; Chang, J.W.; Park, Y.G.; Chung, S.S. 1999: Gamma Knife Radiosurgery for Functioning Pituitary Adenomas. Stereotactic and Functional Neurosurgery 72(1): 101-110
Hayashi, M.; Izawa, M.; Hiyama, H.; Nakamura, S.; Atsuchi, S.; Sato, H.; Nakaya, K.; Sasaki, K.; Ochiai, T.; Kubo, O.; Hori, T.; Takakura, K. 1999: Gamma Knife Radiosurgery for Pituitary Adenomas. Stereotactic and Functional Neurosurgery 72(Suppl 1): 111-118
Kim, M.S.; Lee, S.I.; Sim, J.H. 1999: Gamma Knife Radiosurgery for Functioning Pituitary Microadenoma. Stereotactic and Functional Neurosurgery 72(1): 119-124
Inoue, H.K.; Kohga, H.; Hirato, M.; Sasaki, T.; Ishihara, J.; Shibazaki, T.; Ohye, C.; Andou, Y. 1999: Pituitary Adenomas Treated by Microsurgery with or without Gamma Knife Surgery: Experience in 122 Cases. Stereotactic and Functional Neurosurgery 72(Suppl 1): 125-131
Lim, Y.J.; Leem, W.; Park, J.T.; Kim, T.S.; Rhee, B.A.; Kim, G.K. 1999: Cerebral Infarction with Ica Occlusion after Gamma Knife Radiosurgery for Pituitary Adenoma: A Case Report. Stereotactic and Functional Neurosurgery 72(1): 132-139
Mokry, M. 1999: Craniopharyngiomas: A Six Year Experience with Gamma Knife Radiosurgery. Stereotactic and Functional Neurosurgery 72(1): 140-149
Yu, C.; Luxton, G.; Apuzzo, M.L.J.; Petrovich, Z. 1999: Tld Measurements of the Relative Output Factors for the Leksell Gamma Knife. Stereotactic and Functional Neurosurgery 72(Suppl 1): 150-158
Suh, J.H.; Barnett, G.H.; Miller, D.W.; Crownover, R.L.; Willoughby, T.R.; Weinhous, M.S.; Barrett, P.A.; Walsh, J.G.; Macklis, R.M. 1999: Successful Conversion from a Linear Accelerator-Based Program to a Gamma Knife Radiosurgery Program: The Cleveland Clinic Experience. Stereotactic and Functional Neurosurgery 72(1): 159-167
Kim, M.S.; Lee, S.I.; Sim, J.H. 1999: A Case of Very Large Cyst Formation with Gamma Knife Radiosurgery for an Arteriovenous Malformation. Stereotactic and Functional Neurosurgery 72(1): 168-174
Laitinen, L.V. 2000: Leksells Unpublished Pallidotomies of 19581962. Stereotactic and Functional Neurosurgery 74(1): 1-10
Liu, X.; Aziz, T.Z.; Miall, R.C.; Rowe, J.; Alusi, S.H.; Bain, P.G.; Stein, J.F. 2000: Frequency Analysis of Involuntary Movements during Wrist Tracking: A Way to Identify Ms Patients with Tremor Who Benefit from Thalamotomy. Stereotactic and Functional Neurosurgery 74(2): 53-62
Spincemaille, G.H.; Klomp, H.M.; Steyerberg, E.W.; van Urk, H.; Habbema, J.D.F. 2000: Technical Data and Complications of Spinal Cord Stimulation: Data from a Randomized Trial on Critical Limb Ischemia. Stereotactic and Functional Neurosurgery 74(2): 63-72
Yamamoto, T.; Katayama, Y.; Fukaya, C.; Kurihara, J.; Oshima, H.; Kasai, M. 2000: Thalamotomy Caused by Cardioversion in a Patient Treated with Deep Brain Stimulation. Stereotactic and Functional Neurosurgery 74(2): 73-82
Fountas, K.N.; Kapsalaki, E.Z.; Gotsis, S.D.; Kapsalakis, J.Z.; Smisson III, H.F.; Johnston, K.W.; Robinson Jr., J.S.; Papadakis, N. 2000: In vivo Proton Magnetic Resonance Spectroscopy of Brain Tumors. Stereotactic and Functional Neurosurgery 74(2): 83-94
Katayama, Y.; Kasai, M.; Oshima, H.; Fukaya, C.; Yamamoto, T. 2000: Effects of Anterodorsal Pallidal Stimulation on Gait Freezing (Kinesia paradoxa) in Parkinsons Disease. Stereotactic and Functional Neurosurgery 74(3-4): 99-105
Brophy, B.P. 2000: Acoustic Neuroma Surgery or Radiosurgery?. Stereotactic and Functional Neurosurgery 74(3-4): 121-128
Hashizume, K.; Tanaka, T.; Fujita, T.; Tanaka, S. 2000: Generalized Seizures Induced by an Epileptic Focus in the Mesencephalic Reticular Formation: Impact on the Understanding of the Generalizing Mechanism. Stereotactic and Functional Neurosurgery 74(3-4): 153-160
Chang, J.W.; Chang, J.H.; Park, Y.G.; Chung, S.S. 2000: Microvascular Decompression in Trigeminal Neuralgia: A Correlation of Three-Dimensional Time-of-Flight Magnetic Resonance Angiography and Surgical Findings. Stereotactic and Functional Neurosurgery 74(3-4): 167-174
Gildenberg, P.L. 2000: Multimodality Program Involving Stereotactic Surgery in Brain Tumor Management. Stereotactic and Functional Neurosurgery 74(3-4): 179-184
Ohye, C. 2001: The Idea of Stereotaxy toward Minimally Invasive Neurosurgery. Stereotactic and Functional Neurosurgery 74(3-4): 185-193
Pillay, P.K.; Leo, C.W.; Sethi, D.S. 2000: Computer-Aided/Image-Guided and Video-Endoscopic Resection of Pituitary Tumors. Stereotactic and Functional Neurosurgery 74(3-4): 203-209
Milligan, B.D.; Wilkinson, S.; Overman, J.; Kirschman, D.L.; Koller, W.C.; Pahwa, R.; Lyons, K.E.; Batnitzky, S.; Gordon, M.A. 2001: Magnitude of Microelectrode Refinement in Pallidotomy and Thalamotomy 1. Stereotactic and Functional Neurosurgery 76(1): 2-18
Abbassian, A.H.; Shahzadi, S.; Afraz, S.R.; Fazl, A.; Moradi, F. 2001: Tactile Discrimination Task Not Disturbed by Thalamic Stimulation. Stereotactic and Functional Neurosurgery 76(1): 19-28
Urie, M.M.; Lo, Y.C.; Litofsky, S.; FitzGerald, T.J. 2001: Miniature Multileaf Collimator as an Alternative to Traditional Circular Collimators for Stereotactic Radiosurgery and Stereotactic Radiotherapy. Stereotactic and Functional Neurosurgery 76(1): 47-62
Duffau, H.; Lopes, M.; Denvil, D.; Capelle, L. 2001: Delayed Onset of the Supplementary Motor Area Syndrome after Surgical Resection of the Mesial Frontal Lobe: A Time Course Study Using Intraoperative Mapping in an Awake Patient. Stereotactic and Functional Neurosurgery 76(2): 74-82
Marino, J..,R.; Machado, A.é , G.G.; Timo-Iaria, C.é sar, sar 2001: Functional Recovery after Combined Cerebral and Cerebellar Hemispherectomy in the Rat. Stereotactic and Functional Neurosurgery 76(2): 83-93
Perks, J.; St. George, E.J.; Doughty, D.; Plowman, P.N. 2001: Is Distortion Correction Necessary for Digital Subtraction Angiography in the Gamma Knife Treatment of Intra-Cranial Arteriovenous Malformations?. Stereotactic and Functional Neurosurgery 76(2): 94-105
Johnstone, P.A.S.; Hodgens, D.W.; Ott, K.; Goetsch, S.J. 2001: Risk Management in a Community Gamma Knife Unit. Stereotactic and Functional Neurosurgery 76(2): 106-114
Imai, S.; Haga, S.; Kiyozuka, Y. 1998: Epitope Characterization of Muc1 Antibodies. Tumor Biology 19(Suppl 1): 30-34
Becker, C.; Wigheden, I.; Lilja, H. 1999: Characterization of Epitope Structure for 53 Monoclonal Antibodies against Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 13-17
Bellanger, L.; Andrè, A.è s, C.; Seguin, P. 1999: Epitope Mapping of 53 Antibodies against Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 18-23
Jette, D.C.; Kreutz, F.T.; Suresh, M.R. 1999: Relative Affinity and Specificity of Monoclonal Antibodies against Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 24-27
Leinonen, J.; Zhang, W.-M.; Paus, E.; Stenman, U.-H. 1999: Reactivity of 77 Antibodies to Prostate-Specific Antigen with Isoenzymes and Complexes of Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 28-34
Leinonen, J.; Leinimaa, M.; Zhang, W.-M.; Piironen, T.; Pettersson, K.; Lilja, H.; Dowell, B.; Stenman, U.-H. 1999: Reactivity of Anti-Psa Monoclonal Antibodies with Recombinant Human Kallikrein-2. Tumor Biology 20(Suppl 1): 35-37
Nap, M.; van der Kwast, T.M. 1999: Immunohistochemical Characterization of 53 Monoclonal Antibodies to Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 38-42
Nilsson, O.; Andersson, I.; Peter, A.; Karlsson, B. 1999: Characterization of Antibodies to Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 43-51
Paus, E.; Nustad, K.; Bø, B.ø rmer, O.P. 1999: Epitope Mapping and Affinity Estimation of 83 Antibodies against Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 52-69
Slota, J.; Lauren, L.; Rapp, J.; Dowell, B. 1999: Immunological Grouping of 53 Antibodies against Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 70-74
Zhou, Z.; Barnett, T.R.; Very, D.L.; Ng, P.C.; Pellegrino, C.M.; Davis, G.; Belenky, A.; Allard, W.J.; Yeung, K.K. 1999: Analysis of Monoclonal Antibodies to Prostate-Specific Antigen: Reactivity with Native and Recombinant Prostate-Specific Antigen. Tumor Biology 20(Suppl 1): 86-93